AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2

Clinical trials for AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2 explained in plain language.

Never miss a new study

Get alerted when new AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2 trials appear

Sign up with your email to follow new studies for AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists launch major hunt for clues to mysterious metabolic diseases

Knowledge-focused Recruiting now

This study aims to better understand a group of rare genetic disorders that affect how the body processes certain chemicals, which can cause problems with the brain, blood, kidneys, and immune system. Researchers will observe up to 999 participants, including people with these di…

Matched conditions: AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2

Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused

Last updated Mar 18, 2026 14:55 UTC

AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2

Get alerted when new AICDA, OMIM *605257, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2; HIGM2 trials appear

Scientists launch major hunt for clues to mysterious metabolic diseases